BIO-RAD LABORATORIES, INC. manufactures and supplies to life sciences research, healthcare, analytical chemistry, semiconductor and other markets a broad range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components.
| Revenue (Most Recent Fiscal Year) | $2.57B |
| Net Income (Most Recent Fiscal Year) | $-1.84B |
| PE Ratio (Current Year Earnings Estimate) | -- |
| PE Ratio (Trailing 12 Months) | 23.68 |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | 2.68 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 1.02 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | 24.06 |
| Pre-Tax Margin (Trailing 12 Months) | -108.23% |
| Net Margin (Trailing 12 Months) | -85.16% |
| Return on Equity (Trailing 12 Months) | 4.32% |
| Return on Assets (Trailing 12 Months) | 3.03% |
| Current Ratio (Most Recent Fiscal Quarter) | 5.99 |
| Quick Ratio (Most Recent Fiscal Quarter) | 4.43 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.18 |
| Inventory Turnover (Trailing 12 Months) | 1.50 |
| Book Value per Share (Most Recent Fiscal Quarter) | $234.52 |
| Earnings per Share (Most Recent Fiscal Quarter) | -- |
| Earnings per Share (Most Recent Fiscal Year) | -- |
| Diluted Earnings per Share (Trailing 12 Months) | $-76.20 |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Medical Devices |
| Common Shares Outstanding | 27.21M |
| Free Float | 19.49M |
| Market Capitalization | $6.81B |
| Average Volume (Last 20 Days) | 33.40 |
| Beta (Past 60 Months) | 0.82 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 28.38% |
| Percentage Held By Institutions (Latest 13F Reports) | 0.01% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |